BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2024 9:11:52 AM | Browse: 371 | Download: 1173
Publication Name World Journal of Clinical Cases
Manuscript ID 88298
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Case Report
Article Title Inetetamab combined with pyrotinib and chemotherapy in the treatment of breast cancer brain metastasis: A case report
Manuscript Source Unsolicited Manuscript
All Author List Qing-Qing Dou, Ting-Ting Sun, Guo-Qiang Wang and Wei-Bing Tong
ORCID
Author(s) ORCID Number
Qing-Qing Dou http://orcid.org/0009-0009-1191-758X
Ting-Ting Sun http://orcid.org/0009-0003-1002-2692
Guo-Qiang Wang http://orcid.org/0009-0009-3290-207X
Wei-Bing Tong http://orcid.org/0009-0004-9599-4139
Funding Agency and Grant Number
Corresponding Author Wei-Bing Tong, MD, Chief Physician, Doctor, Doctor, Surgeon, Central Breast Area B, Beijing University Cancer Hospital Inner Mongolia Hospital, No. 42 Zhaowuda Road, Saihan District, Hohhot 010000, Inner Mongolia Autonomous Region, China. tongwei365@qq.com
Key Words Breast cancer brain metastasis; Resistance to trastuzumab; Macromolecule inetetamab; Small molecule tyrosine kinase inhibitor; Radiation therapy; HER2-positive; Case report
Core Tip Herein, we report the case of a patient with complex breast cancer brain metastasis. She underwent brain metastasis resection and received macromolecular mAbs, small molecule tyrosine kinase inhibitors, combination chemotherapeutic drugs, and radiation therapy. The overall condition of the patient was controlled and stabilized. We propose that combined macromolecule and small molecule chemotherapy and radiotherapy can provide a new option for the treatment of patients with breast cancer brain metastases. Magnetic resonance imaging of the brain of the patient showed that the tumor size was stable, and all the tumor indicators were within the normal range.
Publish Date 2024-01-18 09:11
Citation Dou QQ, Sun TT, Wang GQ, Tong WB. Inetetamab combined with pyrotinib and chemotherapy in the treatment of breast cancer brain metastasis: A case report. World J Clin Cases 2024; 12(3): 575-581
URL https://www.wjgnet.com/2307-8960/full/v12/i3/575.htm
DOI https://dx.doi.org/10.12998/wjcc.v12.i3.575
Full Article (PDF) WJCC-12-575-with-cover.pdf
Full Article (Word) WJCC-12-575.docx